Cargando…

Improved Glycemic Control in a Patient Group Performing 7-Point Profile Self-Monitoring of Blood Glucose and Intensive Data Documentation: An Open-Label, Multicenter, Observational Study

INTRODUCTION: Regular self-monitoring of blood glucose (SMBG) is recommended as an integral part of therapy for all patients with diabetes treated with insulin. In the current study, the effects on glycemic control of taking 7-point SMBG profiles and using a diabetes management system (DMA) on a sma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sieber, Jochen, Flacke, Frank, Link, Manuela, Haug, Cornelia, Freckmann, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630561/ https://www.ncbi.nlm.nih.gov/pubmed/28913822 http://dx.doi.org/10.1007/s13300-017-0306-z

Ejemplares similares

Prediction Quality of Glucose Trend Indicators in Two Continuous Tissue Glucose Monitoring Systems
por: Freckmann, Guido, et al.
Publicado: (2018)

Measurement Performance of Two Continuous Tissue Glucose Monitoring Systems Intended for Replacement of Blood Glucose Monitoring
por: Freckmann, Guido, et al.
Publicado: (2018)

System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015
por: Pleus, Stefan, et al.
Publicado: (2020)

Description of a Novel Patch Pump for Insulin Delivery and Comparative Accuracy Evaluation
por: Baumstark, Annette, et al.
Publicado: (2021)

User Performance Evaluation of Four Blood Glucose Monitoring Systems Applying ISO 15197:2013 Accuracy Criteria and Calculation of Insulin Dosing Errors
por: Freckmann, Guido, et al.
Publicado: (2018)

Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion
por: Ziegler, Ralph, et al.
Publicado: (2021)

Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study
por: Waldenmaier, Delia, et al.
Publicado: (2021)

Evaluation of a Methodology for Estimating HbA1c Value by a New Glucose Meter
por: Sieber, Jochen, et al.
Publicado: (2015)

Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems
por: Freckmann, Guido, et al.
Publicado: (2019)

Liraglutide as an Alternative to Insulin for Glycemic Control in Intensive Care Unit: A Randomized, Open-label, Clinical Study
por: Verma, Vishesh, et al.
Publicado: (2017)

First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy
por: Waldenmaier, Delia, et al.
Publicado: (2018)

Effects of ipragliflozin on glycemic control, appetite and its related hormones: A prospective, multicenter, open‐label study (SOAR‐KOBE Study)
por: Miura, Hiroshi, et al.
Publicado: (2019)

Point: Intensive Glycemic Control and Mortality in ACCORD—A Chance Finding?
por: Lachin, John M.
Publicado: (2010)

The Impact of Structured and Standardized Documentation on Documentation Quality; a Multicenter, Retrospective Study
por: Ebbers, Tom, et al.
Publicado: (2022)

Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal–bolus insulin therapy: An open label, prospective, multicenter trial in Japan
por: Ogawa, Wataru, et al.
Publicado: (2020)

Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future?
por: Heinemann, Lutz, et al.
Publicado: (2018)

OASIS OpenDocument essentials : : using OASIS OpenDocument XML /
por: Eisenberg, J David
Publicado: (2005)

The Edoxaban Hokusai VTE PEDIATRICS Study: An open‐label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease
por: van Ommen, Cornelia Heleen, et al.
Publicado: (2020)

Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials
por: Schrangl, Patrick, et al.
Publicado: (2018)

Intensive glycemic control in traumatic brain injury: what is the ideal glucose range?
por: Vespa, Paul M
Publicado: (2008)

An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn’s disease
por: Yoshimura, Naoki, et al.
Publicado: (2015)

Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach): multicentre, open-label, parallel, randomised controlled trial
por: Hermanns, Norbert, et al.
Publicado: (2023)

Clinical efficacy of Professional Continuous Glucose Monitoring in improving glycemic control among children with Type 1 Diabetes Mellitus: An Open-label Randomized Control Trial
por: Raviteja, K. V., et al.
Publicado: (2019)

Transparency, Documentation, and Open Science
por: Isaacowitz, Derek
Publicado: (2020)

Transparency, Documentation, and Open Science
por: Isaacowitz, Derek
Publicado: (2021)

TRANSPARENCY, DOCUMENTATION, AND OPEN SCIENCE
por: Isaacowitz, Derek
Publicado: (2022)

Target for Glycemic Control: Concentrating on glucose
por: Monnier, Louis, et al.
Publicado: (2009)

Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study
por: Pfaar, Oliver, et al.
Publicado: (2015)

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
por: Haak, Thomas, et al.
Publicado: (2016)

Metformin improves glycemic variability in adults with type 1 diabetes mellitus: an open-label randomized control trial
por: Zhang, Xiuzhen, et al.
Publicado: (2021)

GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial
por: Cryer, Byron, et al.
Publicado: (2012)

Glycemic control in Intensive Care Unit
por: Dharmalingam, Mala
Publicado: (2016)

A multicenter, open-label, phase III study of Abcertin in Gaucher disease
por: Lee, Beom Hee, et al.
Publicado: (2017)

Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2019)

An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer’s disease
por: Kainuma, Mosaburo, et al.
Publicado: (2022)

Open notes sounds great, but will a provider’s documentation change? An exploratory study of the effect of open notes on oncology documentation
por: Rahimian, Maryam, et al.
Publicado: (2021)

Glycemic variability is complex - is glucose complexity variable?
por: van Hooijdonk, Roosmarijn TM, et al.
Publicado: (2012)

Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes
por: Perkins, Bruce A., et al.
Publicado: (2015)

Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial
por: Iga, Ryo, et al.
Publicado: (2017)

An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance: Study protocol for investigator-initiated, multicenter, open-label trial
por: Koga, Tomohiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e1bu3r5ok9nkgeqsdi2hda878c